Tarsus Pharmaceuticals In... (TARS)

NASDAQ: TARS · Real-Time Price · USD

50.40

-1.51 (-2.91%)

At close: May 01, 2025, 3:59 PM

46.44

-7.86%

Pre-market: May 02, 2025, 04:48 AM EDT

Tarsus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-115.55M	-135.89M	-62.09M	-13.83M	-26.81M	-4.67M	-1.32M
Depreciation & Amortization	1.23M	877K	325K	312K	96K	37K	1K
Stock-Based Compensation	27.82M	19.83M	13.46M	8.46M	839K	18K	9K
Other Working Capital	-4.31M	4.3M	-1.77M	-2.51M	-1.78M	240K	-5K
Other Non-Cash Items	-360K	-2.61M	227K	5.79M	3.27M	126K	-116K
Deferred Income Tax	n/a	n/a	n/a	1.65M	15K	331K	n/a
Change in Working Capital	3.84M	306K	-951K	1.37M	1.46M	485K	126K
Operating Cash Flow	-83.03M	-117.49M	-49.03M	3.75M	-21.14M	-3.67M	-1.18M
Capital Expenditures	-1.57M	-1.5M	-506K	-586K	-456K	-175K	-7K
Cash Acquisitions	n/a	n/a	144.12M	n/a	n/a	n/a	n/a
Purchase of Investments	-265.63M	-28.66M	-149.44M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	73M	174.77M	5.32M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-5M	-4M	-144.12M	n/a	n/a	n/a	n/a
Investing Cash Flow	-199.19M	140.6M	-144.63M	-586K	-456K	-175K	-7K
Debt Repayment	75M	10M	20M	n/a	n/a	1.99M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-28K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-18.63M	1.58M	-365K	21K	370K	n/a	n/a
Financial Cash Flow	154.66M	130.18M	93.99M	21K	131.77M	59.45M	3.56M
Net Cash Flow	-127.57M	153.29M	-99.67M	3.18M	110.18M	55.6M	2.37M
Free Cash Flow	-84.59M	-123M	-49.54M	3.16M	-21.59M	-3.85M	-1.19M